Introduction
HPeV is a viral genus classification within the family Picornaviridae. It is a RNA virus with 19 discovered genotypes. It is related to enteroviruses and in children can cause gastroenteritis, sepsis and encephalitis. In adults there are published reports of HPeV associated with myocarditis, muscle weakness, myalgia, orchiodynia and fasciitis [1] [2] [3] .
Case description
A 63-year-old male presented to a regional Emergency Department with seizures preceded by four days of confusion. He had a background of alcohol use disorder, hypertension (on Indapamide) and Stage IV cholangiocarcinoma with metastases to the liver, ribs, and lungs. He had undergone radiotherapy, chemotherapy, and biliary stenting.
He experienced two witnessed generalised tonic-clonic seizures ten minutes apart at home, lasting 30 s and four minutes respectively. He reported no preceding meningism, history of seizures, head trauma or ill contacts (specifically young children).
The patient's vital signs, blood work and progress are summarised in Table 1 .
He was disoriented and had difficulty following multi-stage commands. Physical examination was otherwise unremarkable with no neurologic deficits.
A Brain CT scan showed no intracranial haemorrhage or mass. Within 24 h, the patient went into Status Epilepticus manifesting as generalised tonic clonic seizures lasting for up to 25 min. Seizure termination was attempted by administration of Midazolam (IV 5 mg 2 aliquots), given five minutes apart. Therapy was escalated with a Phenytoin load (IV 20 mg/kg). He progressed into RSE warranting intubation with Propofol and Fentanyl and a second loading of Phenytoin. He was transferred to ICU for neurological monitoring and mechanical ventilation.
On Day 2 of admission, a lumbar puncture was performed and treatment for meningoencephalitis was commenced using Ceftriaxone (IV 2 g BD for 1 day), Acyclovir (IV 10 mg/kg TDS for 5 days) and a stat dose of Dexamethasone (IV 10 mg). Given the history of biliary stenting and increasingly cholestatic liver function tests, Metronidazole (IV 500 mg BD for 2 days) was added for potential biliary anaerobic sepsis. Thiamine (IV 300 mg Ongoing Status Epilepticus mandated third line anti-epileptics: Levetiracetam (Loading IV 1 g, Maintenance NGT 500 mg BD) and regular Phenytoin (NGT 300 mg daily) . A sedation break demonstrated ongoing seizure activity and so the Levetiracetam dose was increased (NGT 1 g BD).
On Day 4, lumbar puncture yielded a sterile CSF with elevated protein (0.62 g/L), normal glucose (2.9 mmol/L) and no white blood cells, hence antibiotics were ceased. At this time Parechovirus/viral PCR testing was suggested by Infectious Diseases and Acyclovir was continued for potential Herpes Simplex Virus (HSV). Blood cultures collected prior to the commencement of antibiotics remained negative. CSF enteroviral PCR detected Parechovirus RNA but no HSV. Genotyping could not be performed due to sample size. CSF Paraneoplastic antibodies were negative. Given Parechovirus infection is managed supportively, Acyclovir was ceased.
Phenobarbitone (IV 60 mg) was added for burst suppression and Sodium Valproate (IV 800 mg BD). Partial seizures during sedation breaks were refractory to a midazolam infusion and intermittent boluses. Ventilator dyssynchrony was managed with Dexmedetomidine and ensuing hypotension with Noradrenaline.
On Day 8, he was transferred to a tertiary ICU for twelve days for continuous EEG monitoring. EEG showed active epileptiform focus over the right posterior quadrant, temporal, and occipital lobes. Antiepileptics were rationalised to Sodium Valproate (IV 800 mg BD), Clonazepam (IV 0.5 mg BD), Phenytoin (IV 500 mg daily), and Levetiracetam (IV 1.5 g BD). Amelioration of seizure activity was demonstrated on serial EEGs over ten days with loss of the focal epileptiform pattern but persisting activity over the right hemisphere.
On Day 14, dysphagia complicated extubation, mandating nasogastric feeding.
His admission was complicated by biliary sepsis. On Day 35, he underwent ERCP for biliary stasis/calculi and developed pancreatitis and ascites requiring drainage. Cytology was consistent with cholangiocarcinoma. On Day 44, antiepileptics were weaned and the patient was moved to rehabilitation with residual confusion and right-sided dyspraxia.
During rehabilitation seizure activity was minimal with ongoing bilateral arm tremors and Clonazepam was ceased. Neuropsychological assessment demonstrated ongoing executive cognitive deficit with reduced processing speed and attention.
On Day 63, he was discharged home with frontal lobe release features, driving restrictions, and epilepsy/oncology outpatient follow-up. He passed away 1 month later from progressive refractory malignant ascites.
Discussion
Status Epilepticus is defined as continuous clinical/electrographic seizure activity lasting five minutes or more, or recurrent seizure activity without return to baseline. RSE refers to seizure activity that fails to respond to first line anti-epileptics [4] . Timely seizure control limits neuronal injury and reduces cognitive and behavioural sequelae. The differential diagnoses for new-onset seizures in this patient included, but were not limited to: intracerebral haemorrhage, meningoencephalitis, autoimmune encephalitis, metabolic disturbance, metastatic or primary brain tumour, paraneoplastic encephalitis, alcohol-related seizures and hepatic encephalopathy.
HPeV is spread through contact with saliva, faeces or respiratory droplets from an infected person. This infection coincided with a concurrent outbreak of HPeV amongst children in Victoria, Australia from July 2017-November 2017 [5] . HPeV epidemics tend to occur in a two-yearly cycle with a similar outbreak in Spring 2015. Such epidemiological factors have not previously been associated with adult cases despite the biannual summer to autumn seasonal pattern of HPeV infection. This applies to the genotype HPeV 3, which is the most common cause of aseptic meningitis in North American infants younger than 90 days [6] .
It is unclear why severe disease from HPeV infection is more common in paediatric populations. However, low maternally derived neutralizing antibody titers to HPeV3 are a risk factor for developing serious neonatal sepsis [7] . Gastroenteritis is a common presentation with illness severity being associated with different genotypes. One study describes seizures manifesting in 90% of HPeV-infected infants with meningoencephalitis. Individual cases of acute flaccid paralysis and acute disseminating encephalomyelitis in infants have been reported with the long-term sequelae of white matter injury, cerebral palsy and hypoxic-ischaemic encephalopathy [8] .
As seen with this patient, CNS infections from HPeV 3 typically lack pleocytosis of the CSF [9] . In these cases, detection of RNA in CSF is not predictive of CNS infection and may be the result of spill-over from the blood [10] . As such, real-time reverse transcription-PCR assay testing on CSF fluid and serum may be the most effective tool for detecting this virus in a timely manner. Stool and nasopharyngeal samples may also be tested. This is the first reported case of HPeV causing meningoencephalitis in an adult. This case highlights the devastating effect of RSE that can ensue from infection. It expands the epidemiological knowledge of HPeV and when testing should be performed in adults. Supportive management is the standard of care for HPeV infection with no specific antiviral therapy hence rapid diagnosis will decrease antibiotics therapy.
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